India Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

India Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The India enteral feeding devices market is expected to register a CAGR of 6.5% over the forecast period. The COVID-19 pandemic significantly impacted the enteral feeding devices market in India. People with COVID-19 who are very ill may have decreased nutrient absorption since the normal intestinal mucosa has been disturbed in these patients. Immediate enteral nutrition support and the provision of sufficient nutrients are essential to preventing malnutrition in these patients.

• According to the report published by the MoHFW, India, in 2022, under the management of shock caused by COVID-19 in children and adolescents (below 18 years), enteral nutrition (EN) should be initiated in ventilated and intubated ICU patients via a nasogastric tube. Hence, the COVID-19 pandemic increased the need for enteral feeding devices. Currently, COVID-19 cases are relatively fewer and continuing in India; it is expected to have a significant impact on the enteral feeding devices market over the coming period.
• The major factors responsible for the growth of the Indian enteral feeding devices market include the growing geriatric population, an increase in the premature birth rate, an increasing adoption of enteral nutrition, and the high prevalence of chronic diseases.
• Enteral nutrition (EN) is most commonly required for chronic diseases like neurological conditions that impair swallow function, such as stroke, amyotrophic lateral sclerosis, and Parkinson's disease. Hence the increase in the prevalence of neurological diseases may have a significant impact on the growth of the market.
• For instance, as per the report published by the Lancet Global Health in July 2021, the largest contributors to the total neurological disorder disability-adjusted life years (DALYs) in India were stroke (37·9%), headache disorders (17·5%), epilepsy (11·3%), cerebral palsy (5·7%), and encephalitis (5·3%). Hence, the burden of chronic diseases is growing in India. Chronic patients, who are incapable of taking food, require a good supply of nutrition through enteral feeding, which augments the demand for enteral feeding devices. Therefore, the high prevalence of chronic diseases in India is projected to drive the growth of the market studied over the forecast period.
• However, complications associated with enteral feeding tubes are the major factors restraining the market’s growth.

• Cancer treatment causes many complications and side effects in patients, including mucositis sores in the mouth, difficulty in chewing and swallowing solid food, and altered saliva levels, making it difficult to swallow. The major factor driving the growth of the oncology segment is the rising prevalence of cancer in India. Cancer patients suffer from severe weight loss, as they cannot take proper food, resulting in a shortage of nutrition in the body.
• According to the study by FICCI and EY, published in October 2022, the number of cancer cases recorded in India in 2022 is predicted to be between 19 and 20 lakh, but the actual number of cancer cases would likely be 1.5 to 3 times higher. Thus proper management is necessary for cancer patients. It has been suggested that one plausible strategy for enhancing clinical outcomes is to offer nutrition support to cancer patients, which can be possible through enteral nutrition. Hence enteral feeding plays a major role in feeding the patient by bypassing the oral route, thus driving the market over the study period.
• Furthermore, per the report published by the Journal of Nutrition Research in March 2022, home enteral therapy has several benefits for non-hospitalized patients: reducing adverse treatment effects, enhancing weight benefits, and boosting their energy level. Early enteral nutritional therapy lowers the risk of weight loss and malnutrition compared to oral feeding. Thus, the advantages of enteral feeding are likely to create tremendous opportunities for the market.

• The population of the elderly in India has been increasing, which is a major factor driving the market in the region. As the elderly population increases, the risk of chronic diseases increases, which leads to hospitalizations and increases the demand for enteral feeding devices, and is expected to have a significant growth in the market.
• For instance, as per the study by NSO, in 2021, the proportion of the elderly population in India was projected to be 10.1% in 2021 and 13.1% in 2031. According to the study, the adult population aged above 60 years is considered elderly, and the increasing percentage of the elderly is a key factor for chronic diseases like stroke and cancers in which swallowing becomes difficult. Hence, the study showed a rising in the elderly population, which is expected to increase the demand for enteral feeding due to chronic diseases over the forecast period.
• According to the report published by VJIM in January 2022, patients who have suffered a brain injury, an ischemic or hemorrhagic stroke, or spinal damage should begin early enteral feeding. All these factors can be seen in adults with comorbidities like hypertension and other factors like sudden falls from heights. Hence with an increase in the elderly population, the risk of stroke and spinal injuries increases, and the demand for enteral feeding is likely to increase, which drives the market over the study period.

The Indian enteral feeding devices market is moderately competitive, with the presence of global as well as local players. The major players are competing with each other on various fronts, such as the introduction of new products, increasing geographical penetration, and enhancing distribution channels. The high competition is expected to drive the merger and acquisition activities, thereby leading to market consolidation in a few business segments. The major players include Abbott, B. Braun SE, Boston Scientific Corporation, BD (Becton, Dickinson and Company), CONMED Corporation, Cook Medical Incorporated, Fresenius Se & Co. KGaA, Cardinal Health, and Nestlé.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support